Skip to main content
49°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vyne Therapeutics Inc
(NQ:
VYNE
)
3.030
+0.130 (+4.48%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vyne Therapeutics Inc
< Previous
1
2
3
4
5
Next >
VYNE Stock Earnings: VYNE Therapeutics Misses EPS, Beats Revenue for Q2 2024
August 14, 2024
VYNE stock results show that VYNE Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
June 20, 2024
Via
Benzinga
Analyst Scoreboard: 4 Ratings For VYNE Therapeutics
June 14, 2024
Via
Benzinga
VYNE Stock Earnings: VYNE Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
VYNE stock results show that VYNE Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 06, 2024
Via
Benzinga
Recap: VYNE Therapeutics Q4 Earnings
February 29, 2024
Via
Benzinga
Recap: VYNE Therapeutics Q3 Earnings
November 13, 2023
Via
Benzinga
Recap: VYNE Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 29, 2024
Via
Benzinga
Top 4 Health Care Stocks That May Rocket Higher In Q1
January 16, 2024
The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.
Via
Benzinga
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
January 11, 2024
Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted weaker-than-expected results for its second quarter.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 11, 2024
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!
Via
InvestorPlace
Dow Surges Over 500 Points; Western Digital Announces Plan To Split Into Two Companies
October 30, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 500 points on Monday. The Dow traded up 1.67% to 32,959.68 while the NASDAQ rose 1.25% to 12,800.95. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 30, 2023
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 30, 2023
Via
Benzinga
Positive Momentum For VYNE Therapeutics' Psoriasis, Rheumatoid Arthritis Candidate - Analyst Expresses Encouragement
October 30, 2023
Earlier today, VYNE Therapeutics Inc (NASDAQ: VYNE) released new preclinical data showing the positive effect of its VYN202 in preclinical models of
Via
Benzinga
Crude Oil Falls Over 3%; Miromatrix Medical Shares Spike Higher
October 30, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday. The Dow traded up 1.14% to 32,788.73 while the NASDAQ rose 0.98% to 12,766.33. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Vyne Therapeutics Stock Is Climbing
October 30, 2023
Vyne Therapeutics Inc. (NASDAQ: VYNE) shares are trading higher Monday after the company announced a private placement of $88 million and positive data from its Phase 1b trial.
Via
Benzinga
Nasdaq Gains Over 1%; McDonald's Reports Upbeat Earnings
October 30, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Monday. Following the market opening Monday, the Dow traded up 0.85% to 32,695.89 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 10, 2023
Via
Benzinga
Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results
April 19, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,...
Via
Benzinga
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 12, 2023
Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 19, 2023
Via
Benzinga
VYNE Therapeutics (NASDAQ: VYNE) Shares Positive Preclinical Data for VYN201 as a Potential Treatment for Idiopathic Pulmonary Fibrosis
April 19, 2023
VYNE Therapeutics, Inc. (NASDAQ: VYNE) is engaged as a clinical-stage biopharma company, which is focused on the research and development
Via
Spotlight Growth
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 19, 2023
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.
Via
Benzinga
Why Are VYNE Therapeutics Shares Trading Higher Today?
April 19, 2023
VYNE Therapeutics Inc (NASDAQ: VYNE) announced new preclinical data showing the effect of its novel pan-BET inhibitor, VYN201, in a preclinical model of idiopathic pulmonary fibrosis (IPF).
Via
Benzinga
Vyne Therapeutics Inc. (NASDAQ: VYNE) is One of Wednesday Morning’s Most Active Stocks
April 19, 2023
Via
Investor Brand Network
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.